価格表

在庫・価格 : 2024年06月10日 03時45分 現在

商品名 商品コード メーカー 包装 価格 在庫 リスト
Myostatin, Mouse, Recombinant <GDF-8>
データシート
788-G8-010 RSDアールアンドディー システムス
R&D Systems, Inc.
10 μg ¥89,000 2個 追加

在庫・価格 : 2024年06月10日 03時45分 現在

Myostatin, Mouse, Recombinant <GDF-8>

  • 商品コード:788-G8-010
  • メーカー:RSD
  • 包装:10μg
  • 価格: ¥89,000
  • 在庫:2個
使用文献
No. 文献情報 備考 参照
1 R鱈os R et al. Differential response to exogenous and endogenous myostatin in myoblasts suggests that myostatin acts as an autocrine factor in vivo. Endocrinology 2004 Jun;145(6):2795-803
R鱈os R et al
2004/01/01
Species: Human, Mouse, Rat, Application: Bioassay, Sample type: Whole Cells PubMed
2 Amthor H et al. Follistatin complexes Myostatin and antagonises Myostatin-mediated inhibition of myogenesis. Dev. Biol. 2004 Jun;270(1):19-30
Amthor H et al
2004/01/01
Application: Bioassay, Sample Type: Whole Tissue PubMed
3 Wagner KR et al. Muscle regeneration in the prolonged absence of myostatin. Proc. Natl. Acad. Sci. U.S.A. 2005 Feb;102(7):2519-24
Wagner KR et al
2005/01/01
Application: Bioassay, Sample Type: Whole Cells PubMed
4 Kollias HD et al. Smad7 promotes and enhances skeletal muscle differentiation. Mol. Cell. Biol. 2006 Aug;26(16):6248-60
Kollias HD et al
2006/01/01
Species: Mouse, Application: Bioassay, Sample type: Whole Cells PubMed
5 Ohsawa Y et al. Muscular atrophy of caveolin-3-deficient mice is rescued by myostatin inhibition. J. Clin. Invest. 2006 Nov;116(11):2924-34
Ohsawa Y et al
2006/01/01
Application: Media Supplement, Sample Type: Whole Cells PubMed
6 Miller TM et al. Gene transfer demonstrates that muscle is not a primary target for non-cell-autonomous toxicity in familial amyotrophic lateral sclerosis. Proc. Natl. Acad. Sci. U.S.A. 2006 Dec;103(51):19546-51
Miller TM et al
2006/01/01
Application: Bioassay, Sample Type: Whole Cells PubMed
7 Mukherjee A et al. FSTL3 deletion reveals roles for TGF-beta family ligands in glucose and fat homeostasis in adults. Proc. Natl. Acad. Sci. U.S.A. 2007 Jan;104(4):1348-53
Mukherjee A et al
2007/01/01
Application: Bioassay, Sample Type: Whole Cells PubMed
8 Hamrick MW et al. Loss of myostatin (GDF8) function increases osteogenic differentiation of bone marrow-derived mesenchymal stem cells but the osteogenic effect is ablated with unloading. Bone 2007 Jun;40(6):1544-53
Hamrick MW et al
2007/01/01
Species: Mouse, Application: Bioassay, Sample type: Whole Cells PubMed
9 Huang Z et al. Regulation of myostatin signaling by c-Jun N-terminal kinase in C2C12 cells. Cell. Signal. 2007 Nov;19(11):2286-95
Huang Z et al
2007/01/01
Species: Mouse, Application: Bioassay, Sample type: Whole Cells PubMed
10 Sengle G et al. Targeting of bone morphogenetic protein growth factor complexes to fibrillin. J. Biol. Chem. 2008 May;283(20):13874-88
Sengle G et al
2008/01/01
Species: Human, Application: Biacore binding study, complex formation, recombinant Fibrillin PubMed
11 Sengle G et al. A new model for growth factor activation: type II receptors compete with the prodomain for BMP-7. J. Mol. Biol. 2008 Sep;381(4):1025-39
Sengle G et al
2008/01/01
Species: Human, Application: Biacore binding study, ELISA development, recombinant ActRIA, recombinant ActRIIA, recombinant ActRIIB, recombinant BMPRIA, recombinant BMPRIB, recombinant BMPRII PubMed
12 Wilkes JJ et al. Loss-of-function mutation in myostatin reduces tumor necrosis factor alpha production and protects liver against obesity-induced insulin resistance. Diabetes 2009 May;58(5):1133-43
Wilkes JJ et al
2009/01/01
Application: In Vivo, Sample Type: In Vivo PubMed
13 Cash JN et al. The structure of myostatin:follistatin 288: insights into receptor utilization and heparin binding. EMBO J. 2009 Sep;28(17):2662-76
Cash JN et al
2009/01/01
Application: Binding Assay, Sample Type: Whole Cells PubMed
14 Diel P et al. Analysis of the effects of androgens and training on myostatin propeptide and follistatin concentrations in blood and skeletal muscle using highly sensitive Immuno PCR. Mol. Cell. Endocrinol. 2010 Dec;330(1-2):1-9
Diel P et al
2010/01/01
Application: ELISA Standard, Sample Type: N/A PubMed
15 Wilson TR et al. Widespread potential for growth-factor-driven resistance to anticancer kinase inhibitors. Nature 2012 Jul;487(7408):505-9
Wilson TR et al
2012/01/01
Application: Bioassay, Sample Type: Whole Cells PubMed
16 Sneddon JB et al. Self-renewal of embryonic-stem-cell-derived progenitors by organ-matched mesenchyme. Nature 2012 Nov;491(7426):765-8
Sneddon JB et al
2012/01/01
Application: Cell Culture Substrate, Sample Type: whole cells PubMed
17 Rodgers BD et al. Myostatin stimulates, not inihibits, C2C12 myoblast proliferation. Endocrinology 2014 Mar;155(3):670-5
Rodgers BD et al
2014/01/01
Application: Bioassay, Sample Type: whole cells PubMed
18 Yang Z et al. Screening with a novel cell-based assay for TAZ activators identifies a compound that enhances myogenesis in C2C12 cells and facilitates muscle repair in a muscle injury model. Mol. Cell. Biol. 2014 May;34(9):1607-21
Yang Z et al
2014/01/01
Application: Bioassay, Sample Type: Whole Cells PubMed
19 Biesemann N et al. Myostatin regulates energy homeostasis in the heart and prevents heart failure. Circ. Res. 2014 Jul;115(2):296-310
Biesemann N et al
2014/01/01
Application: Bioassay, Sample Type: Whole Cells PubMed
20 Relizani K et al. Blockade of ActRIIB signaling triggers muscle fatigability and metabolic myopathy. Mol. Ther. 2014 Aug;22(8):1423-33
Relizani K et al
2014/01/01
Application: Bioassay, Sample Type: Whole Cells PubMed
21 Horbelt D et al. Small molecules dorsomorphin and LDN-193189 inhibit myostatin/GDF8 signaling and promote functional myoblast differentiation. J. Biol. Chem. 2015 Feb;290(6):3390-404
Horbelt D et al
2015/01/01
Application: Bioassay, Sample Type: Whole Cells PubMed
22 Latres E et al. Myostatin blockade with a fully human monoclonal antibody induces muscle hypertrophy and reverses muscle atrophy in young and aged mice. Skelet Muscle 2015;5:34
Latres E et al
2015/01/01
Application: Bioassay, Sample Type: Whole Cells PubMed
23 Seto DN et al. A Key Role for Leukemia Inhibitory Factor in C26 Cancer Cachexia. J. Biol. Chem. 2015 Aug;290(32):19976-86
Seto DN et al
2015/01/01
Application: Bioassay, Sample Type: Whole Cells PubMed
24 Walker RG et al. Structural basis for potency differences between GDF8 and GDF11. BMC Biol. 2017 Mar;15(1):19
Walker RG et al
2017/01/01
Application: Bioassay,In Vivo, Sample Type: In Vivo,Whole Cells PubMed
25 Hammers DW et al. Supraphysiological levels of GDF11 induce striated muscle atrophy. EMBO Mol Med 2017 Apr;9(4):531-544
Hammers DW et al
2017/01/01
Application: Bioassay, Sample Type: Whole Cells PubMed
26 Lee SB et al. Maltose binding protein-fusion enhances the bioactivity of truncated forms of pig myostatin propeptide produced in E. coli. PLoS ONE 2017;12(4):e0174956
Lee SB et al
2017/01/01
Application: Bioassay, Sample Type: Whole Cells PubMed
  • No.: 1
  • 文献情報:
    R鱈os R et al. Differential response to exogenous and endogenous myostatin in myoblasts suggests that myostatin acts as an autocrine factor in vivo. Endocrinology 2004 Jun;145(6):2795-803
    R鱈os R et al
    2004/01/01
  • 備考:
    Species: Human, Mouse, Rat, Application: Bioassay, Sample type: Whole Cells
  • 参照:
    PubMed
  • No.: 2
  • 文献情報:
    Amthor H et al. Follistatin complexes Myostatin and antagonises Myostatin-mediated inhibition of myogenesis. Dev. Biol. 2004 Jun;270(1):19-30
    Amthor H et al
    2004/01/01
  • 備考:
    Application: Bioassay, Sample Type: Whole Tissue
  • 参照:
    PubMed
  • No.: 3
  • 文献情報:
    Wagner KR et al. Muscle regeneration in the prolonged absence of myostatin. Proc. Natl. Acad. Sci. U.S.A. 2005 Feb;102(7):2519-24
    Wagner KR et al
    2005/01/01
  • 備考:
    Application: Bioassay, Sample Type: Whole Cells
  • 参照:
    PubMed
  • No.: 4
  • 文献情報:
    Kollias HD et al. Smad7 promotes and enhances skeletal muscle differentiation. Mol. Cell. Biol. 2006 Aug;26(16):6248-60
    Kollias HD et al
    2006/01/01
  • 備考:
    Species: Mouse, Application: Bioassay, Sample type: Whole Cells
  • 参照:
    PubMed
  • No.: 5
  • 文献情報:
    Ohsawa Y et al. Muscular atrophy of caveolin-3-deficient mice is rescued by myostatin inhibition. J. Clin. Invest. 2006 Nov;116(11):2924-34
    Ohsawa Y et al
    2006/01/01
  • 備考:
    Application: Media Supplement, Sample Type: Whole Cells
  • 参照:
    PubMed
  • No.: 6
  • 文献情報:
    Miller TM et al. Gene transfer demonstrates that muscle is not a primary target for non-cell-autonomous toxicity in familial amyotrophic lateral sclerosis. Proc. Natl. Acad. Sci. U.S.A. 2006 Dec;103(51):19546-51
    Miller TM et al
    2006/01/01
  • 備考:
    Application: Bioassay, Sample Type: Whole Cells
  • 参照:
    PubMed
  • No.: 7
  • 文献情報:
    Mukherjee A et al. FSTL3 deletion reveals roles for TGF-beta family ligands in glucose and fat homeostasis in adults. Proc. Natl. Acad. Sci. U.S.A. 2007 Jan;104(4):1348-53
    Mukherjee A et al
    2007/01/01
  • 備考:
    Application: Bioassay, Sample Type: Whole Cells
  • 参照:
    PubMed
  • No.: 8
  • 文献情報:
    Hamrick MW et al. Loss of myostatin (GDF8) function increases osteogenic differentiation of bone marrow-derived mesenchymal stem cells but the osteogenic effect is ablated with unloading. Bone 2007 Jun;40(6):1544-53
    Hamrick MW et al
    2007/01/01
  • 備考:
    Species: Mouse, Application: Bioassay, Sample type: Whole Cells
  • 参照:
    PubMed
  • No.: 9
  • 文献情報:
    Huang Z et al. Regulation of myostatin signaling by c-Jun N-terminal kinase in C2C12 cells. Cell. Signal. 2007 Nov;19(11):2286-95
    Huang Z et al
    2007/01/01
  • 備考:
    Species: Mouse, Application: Bioassay, Sample type: Whole Cells
  • 参照:
    PubMed
  • No.: 10
  • 文献情報:
    Sengle G et al. Targeting of bone morphogenetic protein growth factor complexes to fibrillin. J. Biol. Chem. 2008 May;283(20):13874-88
    Sengle G et al
    2008/01/01
  • 備考:
    Species: Human, Application: Biacore binding study, complex formation, recombinant Fibrillin
  • 参照:
    PubMed
  • No.: 11
  • 文献情報:
    Sengle G et al. A new model for growth factor activation: type II receptors compete with the prodomain for BMP-7. J. Mol. Biol. 2008 Sep;381(4):1025-39
    Sengle G et al
    2008/01/01
  • 備考:
    Species: Human, Application: Biacore binding study, ELISA development, recombinant ActRIA, recombinant ActRIIA, recombinant ActRIIB, recombinant BMPRIA, recombinant BMPRIB, recombinant BMPRII
  • 参照:
    PubMed
  • No.: 12
  • 文献情報:
    Wilkes JJ et al. Loss-of-function mutation in myostatin reduces tumor necrosis factor alpha production and protects liver against obesity-induced insulin resistance. Diabetes 2009 May;58(5):1133-43
    Wilkes JJ et al
    2009/01/01
  • 備考:
    Application: In Vivo, Sample Type: In Vivo
  • 参照:
    PubMed
  • No.: 13
  • 文献情報:
    Cash JN et al. The structure of myostatin:follistatin 288: insights into receptor utilization and heparin binding. EMBO J. 2009 Sep;28(17):2662-76
    Cash JN et al
    2009/01/01
  • 備考:
    Application: Binding Assay, Sample Type: Whole Cells
  • 参照:
    PubMed
  • No.: 14
  • 文献情報:
    Diel P et al. Analysis of the effects of androgens and training on myostatin propeptide and follistatin concentrations in blood and skeletal muscle using highly sensitive Immuno PCR. Mol. Cell. Endocrinol. 2010 Dec;330(1-2):1-9
    Diel P et al
    2010/01/01
  • 備考:
    Application: ELISA Standard, Sample Type: N/A
  • 参照:
    PubMed
  • No.: 15
  • 文献情報:
    Wilson TR et al. Widespread potential for growth-factor-driven resistance to anticancer kinase inhibitors. Nature 2012 Jul;487(7408):505-9
    Wilson TR et al
    2012/01/01
  • 備考:
    Application: Bioassay, Sample Type: Whole Cells
  • 参照:
    PubMed
  • No.: 16
  • 文献情報:
    Sneddon JB et al. Self-renewal of embryonic-stem-cell-derived progenitors by organ-matched mesenchyme. Nature 2012 Nov;491(7426):765-8
    Sneddon JB et al
    2012/01/01
  • 備考:
    Application: Cell Culture Substrate, Sample Type: whole cells
  • 参照:
    PubMed
  • No.: 17
  • 文献情報:
    Rodgers BD et al. Myostatin stimulates, not inihibits, C2C12 myoblast proliferation. Endocrinology 2014 Mar;155(3):670-5
    Rodgers BD et al
    2014/01/01
  • 備考:
    Application: Bioassay, Sample Type: whole cells
  • 参照:
    PubMed
  • No.: 18
  • 文献情報:
    Yang Z et al. Screening with a novel cell-based assay for TAZ activators identifies a compound that enhances myogenesis in C2C12 cells and facilitates muscle repair in a muscle injury model. Mol. Cell. Biol. 2014 May;34(9):1607-21
    Yang Z et al
    2014/01/01
  • 備考:
    Application: Bioassay, Sample Type: Whole Cells
  • 参照:
    PubMed
  • No.: 19
  • 文献情報:
    Biesemann N et al. Myostatin regulates energy homeostasis in the heart and prevents heart failure. Circ. Res. 2014 Jul;115(2):296-310
    Biesemann N et al
    2014/01/01
  • 備考:
    Application: Bioassay, Sample Type: Whole Cells
  • 参照:
    PubMed
  • No.: 20
  • 文献情報:
    Relizani K et al. Blockade of ActRIIB signaling triggers muscle fatigability and metabolic myopathy. Mol. Ther. 2014 Aug;22(8):1423-33
    Relizani K et al
    2014/01/01
  • 備考:
    Application: Bioassay, Sample Type: Whole Cells
  • 参照:
    PubMed
  • No.: 21
  • 文献情報:
    Horbelt D et al. Small molecules dorsomorphin and LDN-193189 inhibit myostatin/GDF8 signaling and promote functional myoblast differentiation. J. Biol. Chem. 2015 Feb;290(6):3390-404
    Horbelt D et al
    2015/01/01
  • 備考:
    Application: Bioassay, Sample Type: Whole Cells
  • 参照:
    PubMed
  • No.: 22
  • 文献情報:
    Latres E et al. Myostatin blockade with a fully human monoclonal antibody induces muscle hypertrophy and reverses muscle atrophy in young and aged mice. Skelet Muscle 2015;5:34
    Latres E et al
    2015/01/01
  • 備考:
    Application: Bioassay, Sample Type: Whole Cells
  • 参照:
    PubMed
  • No.: 23
  • 文献情報:
    Seto DN et al. A Key Role for Leukemia Inhibitory Factor in C26 Cancer Cachexia. J. Biol. Chem. 2015 Aug;290(32):19976-86
    Seto DN et al
    2015/01/01
  • 備考:
    Application: Bioassay, Sample Type: Whole Cells
  • 参照:
    PubMed
  • No.: 24
  • 文献情報:
    Walker RG et al. Structural basis for potency differences between GDF8 and GDF11. BMC Biol. 2017 Mar;15(1):19
    Walker RG et al
    2017/01/01
  • 備考:
    Application: Bioassay,In Vivo, Sample Type: In Vivo,Whole Cells
  • 参照:
    PubMed
  • No.: 25
  • 文献情報:
    Hammers DW et al. Supraphysiological levels of GDF11 induce striated muscle atrophy. EMBO Mol Med 2017 Apr;9(4):531-544
    Hammers DW et al
    2017/01/01
  • 備考:
    Application: Bioassay, Sample Type: Whole Cells
  • 参照:
    PubMed
  • No.: 26
  • 文献情報:
    Lee SB et al. Maltose binding protein-fusion enhances the bioactivity of truncated forms of pig myostatin propeptide produced in E. coli. PLoS ONE 2017;12(4):e0174956
    Lee SB et al
    2017/01/01
  • 備考:
    Application: Bioassay, Sample Type: Whole Cells
  • 参照:
    PubMed